extract: 2026-01-13-aon-glp1-employer-cost-savings-cancer-reduction
Vida Domain Peer Review — PR #1242
GLP-1 employer cost savings / cancer reduction (Aon data enrichment + 4 claims)
Significant issues
1. Kidney claim title contradicted by…
extract: 2026-01-13-aon-glp1-employer-cost-savings-cancer-reduction
- Factual accuracy — The claims are factually correct, and the added evidence from the Aon analysis provides relevant data points to either challenge, extend, or confirm the existing…
extract: 2026-01-01-openevidence-clinical-ai-growth-12b-valuation
- Factual accuracy — The claims introduce new evidence regarding OpenEvidence's adoption, valuation, and performance, which are presented as factual data points from the specified…
extract: 2025-01-01-nashp-chw-state-policies-2024-2025
Vida Domain Peer Review — PR #1235
NASHP CHW State Policies 2024-2025 enrichment
This PR enriches two existing health domain claims using the NASHP CHW policy landscape report. No new…
extract: 2025-06-01-value-in-health-comprehensive-semaglutide-medicare-economics
- Factual accuracy — The claims and entities appear factually correct, with the new evidence providing additional context and sometimes challenging or confirming existing statements. 2.…
extract: 2025-01-01-nashp-chw-state-policies-2024-2025
- Factual accuracy — The new evidence added to both claims appears factually correct, citing specific numbers for CHW reimbursement and ROI.
- Intra-PR duplicates — There are no…
extract: 2026-03-18-telegram-m3taversal-futairdbot-that-isn-t-true-the-ban-hawkin-s-prop
Approved (post-rebase re-approval).